Renishaw Plc · LSE:RSW

Renishaw — Investor Day (May 2014)

12 slides from Renishaw's investor day presentation, May 15, 2014

  1. Slide 1: Investor Day – Neurological Products Division

    Investor Day Neurological Products Division 15th May 2014 Presented by Paul Skinner

  2. Slide 2: Customer needs

    Customer needs • Target market is Functional Neurosurgical Units. – These units require; • High accuracy – specific placement of devices into the brain • High effectiveness – reduced human error • High efficiency – health economic

  3. Slide 3: Examples of Neurosurgical procedures

    Examples of Neurosurgical procedures • DBS - Deep Brain Stimulation – Placement of 2 electrodes into the Subthalamic Nucleus – Typically for the treatment of movement disorders such as Parkinson's disease • SEEG – Stereoelectroencephalography – Treatment of Epilepsy – Replacing sub-cortical grids –

  4. Slide 4: Engineering solutions – a systems approach

    Engineering solutions – a systems approach neuro | mate® neuro | inspire™ IP & Approvals neuro | surgical tooling neuro | administration sets neuro | guide™

  5. Slide 5: neuro inspire surgical planning platform

    neuro I inspire™ surgical planning platform • Rapid, accurate planning of stereotactic surgeries • Multi-planar image reconstruction • Brain atlas • Intuitive planning process • Detailed modelling of implanted devices • Manual anatomy segmentation

  6. Slide 6: neuro mate stereotactic robot

    neuro I mate® stereotactic robot • The first image-guided neurosurgical robot in the world • Used in over 10,000 neurosurgical procedures • More than 30 scientific peer-reviewed publications • In use in leading neurosurgical centres in France, UK, Italy, Germany, Peru, Qatar, KSA and the US (R&D)

  7. Slide 7: Improved precision and increased speed

    Improved precision and increased speed* Precision Average Range DBS2 Frame 1.03 mm 0.62 mm - 1.44 mm Robot 0.81 mm 0.33 mm - 1.29 mm SEEG1 Frame 1.43 mm 0.91 mm - 2.21 mm Robot 0.78 mm 0.49 mm - 1.08 mm Speed Average Range DBS2 Frame 55 min +/- 17 min Robot 23 min +/-13 min *Compared to other stereo

  8. Slide 8: neuro guide DBS electrode delivery system

    neuro | guide™ DBS electrode delivery system • Allows verification of expected DBS lead position relative to targeted anatomy using MRI data • Guide tube: permanent implant bonded to the skull, electrode conduit • Stylette: temporary implant for peri-operative MRI confirmation

  9. Slide 9: Drug delivery – support for Clinician led study

    Drug delivery – support for Clinician led study • Manufacturing an investigational intraparenchymal drug delivery system designed by an NHS Trust • Clinician-led clinical trial for a therapy for the treatment of Parkinson’s disease • This system has also been trialled by the Trust for delivery of a

  10. Slide 10: Successful outcomes – Parkinson's Disease

    Successful outcomes – Parkinson’s Disease • Example of a patient fitted with DBS electrode using the Renishaw neuroguide™ and neuroinspire™ systems

  11. Slide 11: Successful outcomes - Epilepsy

    Successful outcomes - Epilepsy • Stella (aged 13) developed severe epilepsy when she was 1 year old and subsequently endured up to 100 life threatening seizures every day. • Over 10 years, she underwent 5 invasive surgical procedures, and after every procedure, the seizures returned immediately, oft

  12. Slide 12: Thank you

    RENISHAW4) apply innovation™ Thank you

Renishaw — Investor Day (May 2014) on 6ix